PetIQ (PETQ)
(Real Time Quote from BATS)
$19.71 USD
-0.17 (-0.86%)
Updated May 23, 2024 12:40 PM ET
1-Strong Buy of 5 1
A Value F Growth F Momentum D VGM
Price, Consensus and EPS Surprise
PETQ 19.71 -0.17(-0.86%)
Will PETQ be a Portfolio Killer in May?
Zacks Investment Research is releasing its prediction for PETQ based on the 1-3 month trading system that more than doubles the S&P 500.
About Price, Consensus and EPS Surprise
The Price, Consensus and EPS Surprise chart displays the company's stock price along with the consensus estimate and the EPS surprise. Zacks tracks individual sell-side analyst estimates and creates a consensus EPS estimates. The consensus estimate is the average of all the current estimates made available by brokerage analysts. Consensus estimates are more advantageous because they reduce the risk of any single analyst making an incorrect forecast. ZACKS CONSENSUS ESTIMATE = THE AVERAGE OF ALL CURRENT EPS ESTIMATES. EPS Surprise is the difference (expressed as a percentage) between the actual reported quarterly earnings per share (EPS) vs the estimated quarterly EPS. A company that reports $1.10 in actual quarterly EPS vs. $1.00 in estimated quarterly EPS would show a 10% positive EPS surprise. ((Actual EPS - Estimated EPS) / absolute Estimated EPS) *100 = EPS Surprise %.
Zacks News for PETQ
Wall Street Analysts See a 45.22% Upside in PetIQ (PETQ): Can the Stock Really Move This High?
Is PetIQ (PETQ) Stock Undervalued Right Now?
PETQ: What are Zacks experts saying now?
Zacks Private Portfolio Services
Best Value Stocks to Buy for May 20th
PetIQ (PETQ) Gears Up to Report Q1 Earnings: What's in Store?
Baxter International (BAX) Q1 Earnings and Revenues Surpass Estimates
Other News for PETQ
PetIQ, Inc. (PETQ) Q1 2024 Earnings Call Transcript
PetIQ, Inc. 2024 Q1 - Results - Earnings Call Presentation
PetIQ Inc (PETQ) Surpasses Q1 Revenue and Earnings Expectations, Raises 2024 Outlook
Analysts Are Bullish on These Healthcare Stocks: Coherus Biosciences (CHRS), Petiq (PETQ)
Analysts Have Conflicting Sentiments on These Healthcare Companies: Petiq (PETQ), Leafly Holdings, Inc. (LFLY) and AMN Healthcare Services (AMN)